Tilray | TRLY - Beneficio Operativo

Precio De Mercado
8.48
Cambio Diario
0.01 0.12%
Mensual
-5.46%
Anual
1,184.85%
Q2 Expectativa
9.04




Beneficio Operativo Cambio Fecha
Acasti Pharma USD -2.53M 560K 2025-09
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Avita Medical AUD -10.41M 742K 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Cronos Group USD -7.06M 62.31M 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
IQVIA Holdings USD 2.68B 2.1B 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Moderna USD -857M 597M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Organon & Co USD 217M 171M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Tilray USD -20.01M 9.34M 2025-09
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12
Zealand Pharma A/S -707.05M 245.73M 2025-12